Basic mechanisms of migraine and its acute treatment

Pharmacology and Therapeutics

Volumn 136, Issue 3, 2012, Pages 319-333

  Edvinsson, Lars ^a   Villalón, Carlos M ^b   Maassenvandenbrink, Antoinette ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 HT1B 1D receptor agonists; Autonomic nerves; CGRP receptor antagonists; Glutamate receptor antagonists; Migraine pathophysiology; Trigeminovascular reflex

Indexed keywords

AVITRIPTAN; CALCITONIN GENE RELATED PEPTIDE; DIHYDROERGOTAMINE; ERGOTAMINE; GABAPENTIN; GLUTAMATE RECEPTOR AGONIST; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; KAINIC ACID RECEPTOR ANTAGONIST; LASMIDITAN; LY 466195; NEUROKININ A; NEUROPEPTIDE Y; NOCICEPTIN; NORADRENALIN; OLCEGEPANT; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; TELCAGEPANT; TEZAMPANEL; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID; ZOLMITRIPTAN;

ADRENERGIC SYSTEM; BLOOD BRAIN BARRIER; BLOOD VESSEL INNERVATION; BOLD SIGNAL; BRAIN BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CHANNELOPATHY; CHOLINERGIC SYSTEM; CLUSTER HEADACHE; DISEASE SEVERITY; DIZZINESS; FATIGUE; GENETIC ASSOCIATION; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; NERVE FIBER C; NERVOUS SYSTEM; NONHUMAN; PARESTHESIA; PATHOPHYSIOLOGY; PERIKARYON; PHONOPHOBIA; PHOTOPHOBIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SENSORY NERVE; SPREADING CORTICAL DEPRESSION; THORAX DISEASE; TRIGEMINAL NERVE; TRIGEMINOCERVICAL COMPLEX; TRIGEMINUS NEURALGIA;

AUTONOMIC NERVOUS SYSTEM; BLOOD VESSELS; BLOOD-BRAIN BARRIER; BRAIN; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; MIGRAINE DISORDERS; REFLEX; TRIGEMINAL NERVE;

EID: 84867886566     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.08.011     Document Type: Review

References (183)

1. S. Akerman, P.R. Holland, and P.J. Goadsby Diencephalic and brainstem mechanisms in migraine Nat Rev Neurosci 12 2011 570-84
2. V. Anttila, H. Stefansson, M. Kallela, U. Todt, G.M. Terwindt, and M.S. Calafato Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1 Nat Genet 42 2010 869 873
3. A. Arimura, and S. Shioda Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction Front Neuroendocrinol 16 1995 53 88
4. U. Arulmani, A. MaassenVanDenBrink, C.M. Villalón, and P.R. Saxena Calcitonin gene-related peptide and its role in migraine pathophysiology Eur J Pharmacol 500 2004 315 330
5. D. Attwell, A.M. Buchan, S. Charpak, M. Lauritzen, B.A. Macvicar, and E.A. Newman Glial and neuronal control of brain blood flow Nature 468 2010 232 243
6. S.K. Aurora, F. al-Sayeed, and K.M. Welch The cortical silent period is shortened in migraine with aura Cephalalgia 19 1999 708 712
7. A. Bahra, M.S. Matharu, C. Buchel, R.S. Frackowiak, and P.J. Goadsby Brainstem activation specific to migraine headache Lancet 357 2001 1016 1017
8. C. Bernecker, S. Pailer, P. Kieslinger, R. Horejsi, R. Moller, and A. Lechner Increased matrix metalloproteinase activity is associated with migraine and migraine-related metabolic dysfunctions Eur J Neurol 18 2011 571 576
9. S. Bevan, and J. Szolcsanyi Sensory neuron-specific actions of capsaicin: mechanisms and applications Trends Pharmacol Sci 11 1990 330 333
10. H. Bjorklund, T. Hokfelt, M. Goldstein, L. Terenius, and L. Olson Appearance of the noradrenergic markers tyrosine hydroxylase and neuropeptide Y in cholinergic nerves of the iris following sympathectomy J Neurosci 5 1985 1633 1640
11. H. Bolay, U. Reuter, A.K. Dunn, Z. Huang, D.A. Boas, and M.A. Moskowitz Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model Nat Med 8 2002 136 142
12. S.R. Bradley, V.A. Pieribone, W. Wang, C.A. Severson, R.A. Jacobs, and G.B. Richerson Chemosensitive serotonergic neurons are closely associated with large medullary arteries Nat Neurosci 5 2002 401 402
13. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
14. G. Burnstock Changes in expression of autonomic nerves in aging and disease J Auton Nerv Syst 30 Suppl. 1990 S25 S34
15. R. Burstein, H. Yamamura, A. Malick, and A.M. Strassman Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons J Neurophysiol 79 1998 964 982
16. R. Burstein, D. Yarnitsky, I. Goor-Aryeh, B.J. Ransil, and Z.H. Bajwa An association between migraine and cutaneous allodynia Ann Neurol 47 2000 614 624
17. G. Calo, R. Guerrini, A. Rizzi, S. Salvadori, and D. Regoli Pharmacology of nociceptin and its receptor: a novel therapeutic target Br J Pharmacol 129 2000 1261 1283
18. G. Carmignoto, and M. Gomez-Gonzalo The contribution of astrocyte signalling to neurovascular coupling Brain Res Rev 63 2010 138 148
19. 1F receptors) in human brain: focus on brainstem and spinal cord Neuropharmacology 36 1997 535 542
20. G. Casucci, V. Villani, and F. Frediani Central mechanism of action of antimigraine prophylactic drugs Neurol Sci 29 Suppl. 1 2008 S123 S126
21. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
22. S. Ceruti, G. Villa, M. Fumagalli, L. Colombo, G. Magni, and M. Zanardelli Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain J Neurosci 31 2011 3638 3649
23. K.Y. Chan, M. Baun, R. de Vries, A.J. van den Bogaerdt, C.M. Dirven, and A.H.J. Danser Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery Cephalalgia 31 2011 181 189
24. K.Y. Chan, S. Gupta, R. de Vries, A.H.J. Danser, C.M. Villalón, and E. Muñoz-Islas Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model Br J Pharmacol 160 2010 1316 1325
25. K.Y. Chan, S. Vermeersch, J. de Hoon, C.M. Villalón, and A. MaassenVanDenBrink Potential mechanisms of prospective antimigraine drugs: a focus on vascular (side) effects Pharmacol Ther 129 2011 332 351
26. D.I. Chasman, M. Schurks, V. Anttila, B. de Vries, U. Schminke, and L.J. Launer Genome-wide association study reveals three susceptibility loci for common migraine in the general population Nat Genet 43 2011 695 698
27. T. Christiansen, A. Bruun, Y.E. Knight, P.J. Goadsby, and L. Edvinsson Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat J Headache Pain 4 2003 156 163
28. Z. Cohen, G. Bonvento, P. Lacombe, and E. Hamel Serotonin in the regulation of brain microcirculation Prog Neurobiol 50 1996 335 362
29. Z. Cohen, M. Ehret, M. Maitre, and E. Hamel Ultrastructural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: their associations with local blood vessels Neuroscience 66 1995 555 569
30. A. Csati, J. Tajti, A. Kuris, B. Tuka, L. Edvinsson, and K. Warfvinge Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion Neuroscience 202 2012 158 168
31. A. Csati, J. Tajti, B. Tuka, L. Edvinsson, and K. Warfvinge Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion - interaction with the sensory system Brain Res 1435 2012 29 39
32. C. Dahlöf, and A. MaassenVanDenBrink Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment Headache 52 2012 707 714
33. C.J. Dalsgaard, A. Haegerstrand, E. Theodorsson-Norheim, E. Brodin, and T. Hokfelt Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P Histochemistry 83 1985 37 39
34. T. Darland, M.M. Heinricher, and D.K. Grandy Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more Trends Neurosci 21 1998 215 221
35. + pump alpha2 subunit associated with familial hemiplegic migraine type 2 Nat Genet 33 2003 192 196
36. B. de Vries, R.R. Frants, M.D. Ferrari, and A.M.J.M. van den Maagdenberg Molecular genetics of migraine Hum Genet 126 2009 115 132
37. M. Dichgans, T. Freilinger, G. Eckstein, E. Babini, B. Lorenz-Depiereux, and S. Biskup Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine Lancet 366 2005 371 377
38. A. Ducros, C. Denier, A. Joutel, K. Vahedi, A. Michel, and F. Darcel Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia Am J Hum Genet 64 1999 89 98
39. L. Edvinsson Tracing neural connections to pain pathways with relevance to primary headaches Cephalalgia 31 2011 737 747
40. L. Edvinsson, K.Y. Chan, S. Eftekhari, E. Nilsson, R. de Vries, and H. Saveland Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries Cephalalgia 30 2010 1233 1240
41. L. Edvinsson, J.R. Copeland, P.C. Emson, J. McCulloch, and R. Uddman Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects J Cereb Blood Flow Metab 7 1987 45 57
42. L. Edvinsson, A. Degueurce, D. Duverger, E.T. MacKenzie, and B. Scatton Central serotonergic nerves project to the pial vessels of the brain Nature 306 1983 55 57
43. L. Edvinsson, S. Eftekhari, C.A. Salvatore, and K. Warfvinge Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat Mol Cell Neurosci 46 2011 333 339
44. L. Edvinsson, R. Ekman, I. Jansen, J. McCulloch, and R. Uddman Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects J Cereb Blood Flow Metab 7 1987 720 728
45. L. Edvinsson, T. Elsås, N. Suzuki, T. Shimizu, and T.J. Lee Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat Microsc Res Tech 53 2001 221 228
46. L. Edvinsson, P. Emson, J. McCulloch, K. Tatemoto, and R. Uddman Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ Acta Physiol Scand 122 1984 155 163
47. L. Edvinsson, S. Gulbenkian, C.P. Barroso, M. Cunha e Sa, J.M. Polak, and A. Mortensen Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility Peptides 19 1998 1213 1225
48. L. Edvinsson, I. Jansen Olesen, T.A. Kingman, J. McCulloch, and R. Uddman Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP Cephalalgia 15 1995 373 383
49. L. Edvinsson, and D.N. Krause Cerebral Blood Flow and Metabolism 2002 Lippincott Williams Wilkins Philadelphia
50. L. Edvinsson, and M. Linde New drugs in migraine treatment and prophylaxis: telcagepant and topiramate Lancet 376 2010 645 655
51. L. Edvinsson, and J. McCulloch Distribution and vasomotor effects of peptide HI (PHI) in feline cerebral blood vessels in vitro and in situ Regul Pept 10 1985 345 356
52. L. Edvinsson, J. McCulloch, T. Kingman, and R. Uddman On the functional role of the trigemino-cerebrovascular system in the regulation of cerebral circulation C H.J. Owman, J.E. Hardebo, Neural Regulation of the Cerebral Circulation 1986 Elsevier Science Amsterdam 407 418
53. L. Edvinsson, J. McCulloch, and R. Uddman Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ J Physiol 318 1981 251 258
54. L. Edvinsson, H. Mulder, P.J. Goadsby, and R. Uddman Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide J Auton Nerv Syst 70 1998 15 22
55. L. Edvinsson, E. Nilsson, and I. Jansen-Olesen Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery Br J Pharmacol 150 2007 633 640
56. L. Edvinsson, and P. Tfelt-Hansen The blood-brain barrier in migraine treatment Cephalalgia 28 2008 1245 1258
57. L. Edvinsson, and R. Uddman Neurobiology in primary headaches Brain Res Brain Res Rev 48 2005 438 456
58. S. Eftekhari, and L. Edvinsson CGRP and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level BMC Neurosci 12 2011 112
59. S. Eftekhari, C.A. Salvatore, A. Calamari, S.A. Kane, J. Tajti, and L. Edvinsson Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion Neuroscience 169 2010 683 696
60. S.R. Eid Therapeutic targeting of TRP channels - the TR(i)P to pain relief Curr Top Med Chem 11 2011 2118 2130
61. C. Ertsey, M. Hantos, G. Bozsik, and K. Tekes Circulating nociceptin levels during the cluster headache period Cephalalgia 24 2004 280 283
62. M. Fanciullacci, M. Alessandri, M. Figini, P. Geppetti, and S. Michelacci Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack Pain 60 1995 119 123
63. M. Fanciullacci, M. Alessandri, R. Sicuteri, and S. Marabini Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients Brain 120 Pt 2 1997 283 288
64. H.L. Fields, and A.I. Basbaum Central nervous system mechanisms of pain modulation P.D. Wall, R. Melzack, Textbook of Pain 1994 Churchill Livingstone Edinburgh
65. L. Friberg, J. Olesen, T.S. Olsen, A. Karle, R. Ekman, and J. Fahrenkrug Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura Cephalalgia 14 1994 47 54
66. B. Fricke, M. von During, and K.H. Andres Topography and immunocytochemical characterization of nerve fibers in the leptomeningeal compartments of the rat. A light- and electron-microscopical study Cell Tissue Res 287 1997 11 22
67. M. Gervil, V. Ulrich, K.O. Kyvik, J. Olesen, and M.B. Russell Migraine without aura: a population-based twin study Ann Neurol 46 1999 606 611
68. S. Giuliani, A. Lecci, and C.A. Maggi Nociceptin and neurotransmitter release in the periphery Peptides 21 2000 977 984
69. P.J. Goadsby, D.W. Dodick, M. Almas, H.C. Diener, P. Tfelt-Hansen, and R.B. Lipton Treatment-emergent CNS symptoms following triptan therapy are part of the attack Cephalalgia 27 2007 254 262
70. P.J. Goadsby, and L. Edvinsson The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats Ann Neurol 33 1993 48 56
71. 1D receptor agonist 311C90 Headache 34 1994 394 399
72. P.J. Goadsby, and L. Edvinsson Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies Brain 117 Pt 3 1994 427 434
73. P.J. Goadsby, L. Edvinsson, and R. Ekman Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system Ann Neurol 23 1988 193 196
74. P.J. Goadsby, R.B. Lipton, and M.D. Ferrari Migraine - current understanding and treatment N Engl J Med 346 2002 257 270
75. P.J. Goadsby, and A.S. Zagami Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat Brain 114 1991 1001 1011
76. E.V. Golanov, and D.J. Reis Cerebral cortical neurons with activity linked to central neurogenic spontaneous and evoked elevations in cerebral blood flow Neurosci Lett 209 1996 101 104
77. C. Gonzalez, C. Barroso, C. Martin, S. Gulbenkian, and C. Estrada Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries J Cereb Blood Flow Metab 17 1997 977 984
78. K. Grosser, R. Oelkers, T. Hummel, G. Geisslinger, K. Brune, and G. Kobal Olfactory and trigeminal event-related potentials in migraine Cephalalgia 20 2000 621 631
79. S. Gulbenkian, A. Valenca, J. Wharton, J.M. Polak, and J.F. David-Ferreira Simultaneous visualization of neuropeptide and acetylcholinesterase nerve subpopulations in the perivascular plexus Histochem J 23 1991 553 558
80. A. Guo, L. Vulchanova, J. Wang, X. Li, and R. Elde Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites Eur J Neurosci 11 1999 946 958
81. 1B/1D and CGRP receptors Pharmacol Ther 128 2010 170 190
82. N. Hadjikhani, M. Sanchez Del Rio, O. Wu, D. Schwartz, D. Bakker, and B. Fischl Mechanisms of migraine aura revealed by functional MRI in human visual cortex Proc Natl Acad Sci U S A 98 2001 4687 4692
83. E. Hamel Perivascular nerves and the regulation of cerebrovascular tone J Appl Physiol 100 2006 1059 1064
84. M. Hansenne, W. Pitchot, E. Pinto, P. Papart, and M. Ansseau Serotonergic-1a activity and contingent negative variation Biol Psychol 52 2000 259 265
85. J. Hanze, W. Kummer, M. Haass, and R.E. Lang Neuropeptide Y mRNA regulation in rat sympathetic ganglia: effect of reserpine Neurosci Lett 124 1991 119 121
86. T.W. Ho, L. Edvinsson, and P.J. Goadsby CGRP and its receptors provide new insights into migraine pathophysiology Nat Rev Neurol 6 2010 573 582
87. T.W. Ho, M.D. Ferrari, D.W. Dodick, V. Galet, J. Kost, and X. Fan Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 372 2008 2115 2123
88. J. Hoffmann, S. Wecker, L. Neeb, U. Dirnagl, and U. Reuter Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF Cephalalgia 32 2012 659 667
89. H. Holthusen, D. Kindgen-Milles, and Z.P. Ding Substance P is not involved in vascular nociception in humans Neuropeptides 31 1997 445 448
90. K.L. Hoskin, D.C. Bulmer, and P.J. Goadsby Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by l-NAME Neurosci Lett 266 1999 173 176
91. 1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase Brain Res 909 2001 112 120
92. M. Hou, R. Uddman, J. Tajti, and L. Edvinsson Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion Brain Res 964 2003 179 186
93. M. Hou, R. Uddman, J. Tajti, M. Kanje, and L. Edvinsson Capsaicin receptor immunoreactivity in the human trigeminal ganglion Neurosci Lett 330 2002 223 226
94. P.P.A. Humphrey The discovery and development of the triptans, a major therapeutic breakthrough Headache 48 2008 685 687
95. K. Ikeda, M. Watanabe, T. Ichikawa, T. Kobayashi, R. Yano, and T. Kumanishi Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems J Comp Neurol 399 1998 139 151
96. K. Imamura, T. Takeshima, E. Fusayasu, and K. Nakashima Increased plasma matrix metalloproteinase-9 levels in migraineurs Headache 48 2008 135 139
97. I. Jansen-Olesen, P.J. Goadsby, R. Uddman, and L. Edvinsson VIP-like peptides in the cerebral circulation of the cat J Auton Nerv Syst 49 Suppl. 1994 S97 S103
98. G. Juhasz, T. Zsombok, B. Jakab, J. Nemeth, J. Szolcsanyi, and G. Bagdy Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack Cephalalgia 25 2005 179 183
99. G. Juhasz, T. Zsombok, E.A. Modos, S. Olajos, B. Jakab, and J. Nemeth NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release Pain 106 2003 461 470
100. H. Kaube, K.A. Keay, K.L. Hoskin, R. Bandler, and P.J. Goadsby Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat Brain Res 629 1993 95 102
101. Y.E. Knight, L. Edvinsson, and P.J. Goadsby Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288 Neuropeptides 33 1999 41 46
102. E. Knyihar-Csillik, J. Tajti, A.E. Csillik, Z. Chadaide, A. Mihaly, and L. Vecsei Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model Eur J Neurosci 12 2000 3991 4002
103. R.C. Koehler, R.J. Roman, and D.R. Harder Astrocytes and the regulation of cerebral blood flow Trends Neurosci 32 2009 160 169
104. E.E. Kors, J. Haan, N.J. Giffin, L. Pazdera, C. Schnittger, and G.G. Lennox Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine Arch Neurol 60 2003 684 688
105. L.S. Krimer, E.C. Muly III, G.V. Williams, and P.S. Goldman-Rakic Dopaminergic regulation of cerebral cortical microcirculation Nat Neurosci 1 1998 286 289
106. B. Larrosa, J. Pastor, L. Lopez-Aguado, and O. Herreras A role for glutamate and glia in the fast network oscillations preceding spreading depression Neuroscience 141 2006 1057 1068
107. M. Lauritzen Pathophysiology of the migraine aura. The spreading depression theory Brain 117 Pt 1 1994 199 210
108. T.J. Lee Direct evidence against acetylcholine as the dilator transmitter in the cat cerebral artery Eur J Pharmacol 68 1980 393 394
109. T.J. Lee Nitric oxide and the cerebral vascular function J Biomed Sci 7 2000 16 26
110. 1D receptor agonists Proc Natl Acad Sci U S A 101 2004 4274 4279
111. A.S. Link, A. Kuris, and L. Edvinsson Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system J Headache Pain 9 2008 5 12
112. Y. Liu, J. Broman, and L. Edvinsson Central projections of sensory innervation of the rat superior sagittal sinus Neuroscience 129 2004 431 437
113. Y. Liu, J. Broman, M. Zhang, and L. Edvinsson Brainstem and thalamic projections from a craniovascular sensory nervous center in the rostral cervical spinal dorsal horn of rats Cephalalgia 29 2009 935 948
114. Y. Liu, M. Zhang, J. Broman, and L. Edvinsson Central projections of sensory innervation of the rat superficial temporal artery Brain Res 966 2003 126 133
115. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs Cephalalgia 17 1997 833 842
116. H.C. Lou, L. Edvinsson, and E.T. MacKenzie The concept of coupling blood flow to brain function: revision required? Ann Neurol 22 1987 289 297
117. J.M. Lundberg, T. Hokfelt, A. Hemsen, E. Theodorsson-Norheim, J. Pernow, and B. Hamberger Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients Regul Pept 13 1986 169 182
118. C.F. Marfurt, and D.R. Del Toro Corneal sensory pathway in the rat: a horseradish peroxidase tracing study J Comp Neurol 261 1987 450 459
119. A. Markovics, V. Kormos, B. Gaszner, A. Lashgarara, E. Szoke, and K. Sandor Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice Neurobiol Dis 45 2012 633 644
120. S. Markowitz, K. Saito, and M.A. Moskowitz Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain J Neurosci 7 1987 4129 4136
121. N.T. Mathew Pathophysiology of chronic migraine and mode of action of preventive medications Headache 51 Suppl. 2 2011 84 92
122. N.T. Mathew, and S.F. Jaffri A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study Headache 49 2009 1466 1478
123. A. May, H. Kaube, C. Buchel, R.S. Eichten, M. Rijntjes, M. Juptner, C. Weiller, and H.C. Diener Experimental cranial pain elicited by capsaicin: A PET study Pain 74 1998 61 66
124. A. May, A. Bahra, C. Buchel, R.S. Frackowiak, and P.J. Goadsby PET and MRA findings in cluster headache and MRA in experimental pain Neurology 55 2000 1328 1335
125. A. May, and P.J. Goadsby Substance P receptor antagonists in the therapy of migraine Expert Opin Investig Drugs 10 2001 673 678
126. J. McCulloch, R. Uddman, T.A. Kingman, and L. Edvinsson Calcitonin gene-related peptide: functional role in cerebrovascular regulation Proc Natl Acad Sci U S A 83 1986 5731 5735
127. J.C. Meunier, C. Mollereau, L. Toll, C. Suaudeau, C. Moisand, and P. Alvinerie Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor Nature 377 1995 532 535
128. F.J. Miao, and T.J. Lee Cholinergic and VIPergic innervation in cerebral arteries: a sequential double-labeling immunohistochemical study J Cereb Blood Flow Metab 10 1990 32 37
129. K. Moller, Y.Z. Zhang, R. Hakanson, A. Luts, B. Sjolund, and R. Uddman Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence Neuroscience 57 1993 725 732
130. C. Mollereau, M. Parmentier, P. Mailleux, J.L. Butour, C. Moisand, and P. Chalon ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization FEBS Lett 341 1994 33 38
131. 2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices Eur J Neurosci 28 2008 2213 2220
132. 1F receptor agonist lasmiditan Cephalalgia 30 2010 1159 1169
133. B. Nilius, G. Owsianik, T. Voets, and J.A. Peters Transient receptor potential cation channels in disease Physiol Rev 87 2007 165 217
134. K. Nozaki, M.A. Moskowitz, K.I. Maynard, N. Koketsu, T.M. Dawson, and D.S. Bredt Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries J Cereb Blood Flow Metab 13 1993 70 79
135. J. Olesen, H.C. Diener, I.W. Husstedt, P.J. Goadsby, D. Hall, and U. Meier Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N Engl J Med 350 2004 1104 1110
136. J. Olesen, L. Friberg, T.S. Olsen, H.K. Iversen, N.A. Lassen, and A.R. Andersen Timing and topography of cerebral blood flow, aura, and headache during migraine attacks Ann Neurol 28 1990 791 798
137. J. Olesen, P.J. Goadsby, N.M. Ramadan, P. Tfelt-Hansen, and K.M.A. Welch The Headaches Third Edition 2006 Lipincott, Williams & Wilkins Philadelphia
138. J. Olesen, L.L. Thomsen, L.H. Lassen, and I. Jansen-Olesen The nitric oxide hypothesis of migraine and other vascular headaches Cephalalgia 15 1995 94 100
139. K.R. Oliver, A. Wainwright, L. Edvinsson, J.D. Pickard, and R.G. Hill Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature J Cereb Blood Flow Metab 22 2002 620 629
140. G.A. Olson, R.D. Olson, and A.J. Kastin Endogenous opiates: 1993 Peptides 15 1994 1513 1556
141. 2+ channel gene CACNL1A4 Cell 87 1996 543 552
142. A. Ottosson, and L. Edvinsson Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide Cephalalgia 17 1997 166 174
143. Z. Pan, N. Hirakawa, and H.L. Fields A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin Neuron 26 2000 515 522
144. R.D. Piper, L. Edvinsson, R. Ekman, and G.A. Lambert Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine Cephalalgia 13 1993 180 183
145. J. Regidor, L. Edvinsson, and I. Divac NOS neurons lie near branchings of cortical arteriole NeuroReport 4 1993 112 114
146. M. Riedl, S. Shuster, L. Vulchanova, J. Wang, H.H. Loh, and R. Elde Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord Neuroreport 7 1996 1369 1372
147. M. Samsam, R. Covenas, R. Ahangari, J. Yajeya, J.A. Narvaez, and G. Tramu Alterations in neurokinin A-, substance P- and calcitonin gene-related peptide immunoreactivities in the caudal trigeminal nucleus of the rat following electrical stimulation of the trigeminal ganglion Neurosci Lett 261 1999 179 182
148. M. Sanchez-Del-Rio, U. Reuter, and M.A. Moskowitz New insights into migraine pathophysiology Curr Opin Neurol 19 2006 294 298
149. P.S. Sandor, J. Afra, A.P. Proietti Cecchini, A. Albert, and J. Schoenen From neurophysiology to genetics: cortical information processing in migraine underlies familial influences - a novel approach Funct Neurol 15 Suppl. 3 2000 68 72
150. K. Schepelmann, A. Ebersberger, M. Pawlak, M. Oppmann, and K. Messlinger Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat Neuroscience 90 1999 543 554
151. 1F receptor agonist LY334370 Cephalalgia 19 1999 851 858
152. S.L. Shepheard, D.J. Williamson, R.G. Hill, and R.J. Hargreaves The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats Br J Pharmacol 108 1993 11 12
153. S.D. Silberstein, and D.C. McCrory Ergotamine and dihydroergotamine: history, pharmacology, and efficacy Headache 43 2003 144 166
154. M. Siniatchkin, W.D. Gerber, P. Kropp, T. Voznesenskaya, and A.M. Vein Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity? Cephalalgia 20 2000 20 29
155. 1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks Neurol Neurochir Pol 37 2003 1013 1023
156. R.J. Storer, S. Akerman, and P.J. Goadsby CGRP modulates nociceptive trigeminovascular transmission in the cat Br J Pharmacol 142 2004 1171 1181
157. A.M. Strassman, S.A. Raymond, and R. Burstein Sensitization of meningeal sensory neurons and the origin of headaches Nature 384 1996 560 564
158. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders: 2nd edition Cephalalgia 24 Suppl. 1 2004 9 160
159. N. Suzuki, J.E. Hardebo, and C. Owman Origins and pathways of choline acetyltransferase-positive parasympathetic nerve fibers to cerebral vessels in rat J Cereb Blood Flow Metab 10 1990 399 408
160. A. Szallasi, and P.M. Blumberg Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin Neurosci Lett 140 1992 51 54
161. A. Szallasi, and P.M. Blumberg Vanilloid (capsaicin) receptors and mechanisms Pharmacol Rev 51 1999 159 212
162. J. Tajti, S. Moller, R. Uddman, I. Bodi, and L. Edvinsson The human superior cervical ganglion: neuropeptides and peptide receptors Neurosci Lett 263 1999 121 124
163. J. Tajti, R. Uddman, S. Moller, F. Sundler, and L. Edvinsson Messenger molecules and receptor mRNA in the human trigeminal ganglion J Auton Nerv Syst 76 1999 176 183
164. G.M. Terwindt, R.A. Ophoff, J. Haan, M.N. Vergouwe, R. van Eijk, and R.R. Frants Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine Neurology 50 1998 1105 1110
165. P.C. Tfelt-Hansen Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain 11 2010 5 12
166. Y.R. Tran Dinh, C. Thurel, G. Cunin, A. Serrie, and J. Seylaz Cerebral vasodilation after the thermocoagulation of the trigeminal ganglion in humans Neurosurgery 31 1992 658 662
167. B. Tuka, Z. Helyes, A. Markovics, T. Bagoly, J. Nemeth, and L. Mark Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system Peptides 33 2012 307 316
168. R. Uddman, J. Tajti, M. Hou, F. Sundler, and L. Edvinsson Neuropeptide expression in the human TNC and in the cervical spinal cord C1 and C2 Cephalalgia 22 2002 112 116
169. R. Uddman, J. Tajti, S. Moller, F. Sundler, and L. Edvinsson Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia Brain Res 826 1999 193 199
170. V. Ulrich, M. Gervil, K.O. Kyvik, J. Olesen, and M.B. Russell Evidence of a genetic factor in migraine with aura: a population-based Danish twin study Ann Neurol 45 1999 242 246
171. A.M.J.M. van den Maagdenberg, J. Haan, G.M. Terwindt, and M.D. Ferrari Migraine: gene mutations and functional consequences Curr Opin Neurol 20 2007 299 305
172. W. van der Kamp, A. MaassenVanDenBrink, M.D. Ferrari, and J.G. van Dijk Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation J Neurol Sci 139 1996 106 110
173. C.M. Villalón, D. Centurión, L.F. Valdivia, P. de Vries, and P.R. Saxena Migraine: pathophysiology, pharmacology, treatment and future trends Curr Vasc Pharmacol 1 2003 71 84
174. C.M. Villalón, and J. Olesen The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs Pharmacol Ther 124 2009 309 323
175. M. Wahl, L. Schilling, A.A. Parsons, and A. Kaumann Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression Brain Res 637 1994 204 210
176. C. Weiller, A. May, V. Limmroth, M. Juptner, H. Kaube, and R.V. Schayck Brain stem activation in spontaneous human migraine attacks Nat Med 1 1995 658 660
177. D.J. Williamson, R.J. Hargreaves, R.G. Hill, and S.L. Shepheard Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies Cephalalgia 17 1997 525 531
178. D.J. Williamson, R.J. Hargreaves, R.G. Hill, and S.L. Shepheard Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat Cephalalgia 17 1997 518 524
179. R.P. Woods, M. Iacoboni, and J.C. Mazziotta Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache N Engl J Med 331 1994 1689 1692
180. Y. Xiao, J.A. Richter, and J.H. Hurley Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling Mol Pain 4 2008 12
181. A.S. Zagami, L. Edvinsson, K.L. Hoskin, and P.J. Goadsby Stimulation of the superior sagittal sinus causes extracranial release of PACAP Cephalalgia 15 1995 109
182. W. Zhang, M.O. Lopez-Figuera, J. Regidor, I. Divac, and L. Edvinsson Nitric oxide synthase-containing-neurons innervate human and rat intracortical microvessels Cell Vision 2 1995 105 110
183. Z. Zhang, C.S. Winborn, B. Marquez de Prado, and A.F. Russo Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion J Neurosci 27 2007 2693 2703